Calcimimetic r-568 and its enantiomer s-568 increase nitric oxide release in human endothelial cells

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Bonomini, Mario ^a   Giardinelli, Annalisa ^a   Morabito, Caterina ^a   Silvestre, Sara ^a   Cesare, Moreno ^a   Di Pietro, Natalia ^a   Sirolli, Vittorio ^a   Formoso, Gloria ^a   Amoroso, Luigi ^a   Mariggiò, Maria Addolorata ^a   Pandolfi, Assunta ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMIMETIC AGENT; CALCIUM SENSING RECEPTOR; NITRIC OXIDE; ANILINE DERIVATIVE; CALCIUM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N (2 CHLOROPHENYLPROPYL) 1 (3 METHOXYPHENYL)ETHYLAMINE; N-(2-CHLOROPHENYLPROPYL)-1-(3-METHOXYPHENYL)ETHYLAMINE;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CONTROLLED STUDY; CYTOPLASM; ENANTIOMER; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNORADIOMETRIC ASSAY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WESTERN BLOTTING; AORTA; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; EXTRACELLULAR SPACE; FEMALE; GENE EXPRESSION REGULATION; INTRACELLULAR SPACE; METABOLISM; SECRETION; STEREOISOMERISM; UMBILICAL VEIN ENDOTHELIAL CELL;

ANILINE COMPOUNDS; AORTA; CALCIMIMETIC AGENTS; CALCIUM; ENZYME ACTIVATION; EXTRACELLULAR SPACE; FEMALE; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTRACELLULAR SPACE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RECEPTORS, CALCIUM-SENSING; STEREOISOMERISM;

EID: 84856290485     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030682     Document Type: Article

References (39)

1. Drueke TB, Ritz E, (2009) Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives. Clin J Am Soc Nephrol 4: 234-241.
2. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, et al. (1993) Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 366: 575-580.
3. Nagano N, (2006) Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism. Pharmacol Ther 109: 339-365.
4. Aida K, Koishi S, Tawata M, Onaya T, (1995) Molecular cloning of a putative Ca(2+)-sensing receptor cDNA from human kidney. Biochem Biophys Res Commun 214: 524-529.
5. Smajilovic S, Tfelt-Hansen J, (2007) Calcium acts as a first messenger through the calcium-sensing receptor in the cardiovascular system. Cardiovasc Res 75: 457-467.
6. Nemeth EF, (2004) Calcimimetic and calcilytic drugs: just for parathyroid cells? Cell Calcium 35: 283-289.
7. Nemeth EF, Heaton WH, Miller M, Fox J, Balandrin MF, et al. (2004) Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J Pharmacol Exp Ther 308: 627-635.
8. Strippoli GF, Tong A, Palmer SC, Elder G, Craig JC, (2006) Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database Syst Rev.
9. Brown EM, (2007) The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics. Subcell Biochem 45: 139-167.
10. Weston AF, Absi M, Ward DT, Ohanian J, Dodd RH, et al. (2005) Evidence in favor of a calcium-sensing receptor in arterial endothelial cells: studies with calindol and Calhex 231. Circ Res 97: 391-398.
11. Ziegelstein RC, Xiong Y, He C, Hu Q, (2006) Expression of a functional extracellular calcium-sensing receptor in human aortic endothelial cells. Biochem Biophys Res Commun 342: 153-163.
12. Ohanian J, Gatfield KM, Ward DT, Ohanian V, (2005) Evidence for a functional calcium-sensing receptor that modulates myogenic tone in rat subcutaneous small arteries. Am J Physiol Heart Circ Physiol 288: H1756-1762.
13. Wellendorph P, Burhenne N, Christiansen B, Walter B, Schmale H, et al. (2007) The rat GPRC6A: cloning and characterization. Gene 396: 257-267.
14. Harno E, Edwards G, Geraghty AR, Ward DT, Dodd RH, et al. (2008) Evidence for the presence of GPRC6A receptors in rat mesenteric arteries. Cell Calcium 44: 210-219.
15. Pi M, Faber P, Ekema G, Jackson PD, Ting A, et al. (2005) Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem 280: 40201-40209.
16. Sutherland SK, Benishin CG, (2004) Regulation of parathyroid hypertensive factor secretion by Ca2+ in spontaneously hypertensive rat parathyroid cells. Am J Hypertens 17: 266-272.
17. Odenwald T, Nakagawa K, Hadtstein C, Roesch F, Gohlke P, et al. (2006) Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats. J Am Soc Nephrol 17: 655-662.
18. Rybczynska A, Boblewski K, Lehmann A, Orlewska C, Foks H, (2006) Pharmacological activity of calcimimetic NPS R-568 administered intravenously in rats: dose dependency. Pharmacol Rep 58: 533-539.
19. Rybczynska A, Boblewski K, Lehmann A, Orlewska C, Foks H, et al. (2005) Calcimimetic NPS R-568 induces hypotensive effect in spontaneously hypertensive rats. Am J Hypertens 18: 364-371.
20. Koleganova N, Piecha G, Ritz E, Schmitt CP, Gross ML, (2009) A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia. Kidney Int 75: 60-71.
21. Villar IC, Francis S, Webb A, Hobbs AJ, Ahluwalia A, (2006) Novel aspects of endothelium-dependent regulation of vascular tone. Kidney Int 70: 840-853.
22. Andrew PJ, Mayer B, (1999) Enzymatic function of nitric oxide synthases. Cardiovasc Res 43: 521-531.
23. Nakagawa K, Parekh N, Koleganova N, Ritz E, Schaefer F, et al. (2009) Acute cardiovascular effects of the calcimimetic R-568 and its enantiomer S-568 in rats. Pediatr Nephrol 24: 1385-1389.
24. Thakore P, Ho WS, (2011) Vascular actions of calcimimetics: role of Ca(2)(+)-sensing receptors versus Ca(2)(+) influx through L-type Ca(2)(+) channels. Br J Pharmacol 162: 749-762.
25. Fleming I, Busse R, (2003) Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 284: R1-12.
26. Molostvov G, James S, Fletcher S, Bennett J, Lehnert H, et al. (2007) Extracellular calcium-sensing receptor is functionally expressed in human artery. Am J Physiol Renal Physiol 293: F946-955.
27. Pace AJ, Gama L, Breitwieser GE, (1999) Dimerization of the calcium-sensing receptor occurs within the extracellular domain and is eliminated by Cys--> Ser mutations at Cys101 and Cys236. J Biol Chem 274: 11629-11634.
28. Jensen AA, Brauner-Osborne H, (2007) Allosteric modulation of the calcium-sensing receptor. Curr Neuropharmacol 5: 180-186.
29. Inesi G, Hua S, Xu C, Ma H, Seth M, et al. (2005) Studies of Ca2+ ATPase (SERCA) inhibition. J Bioenerg Biomembr 37: 365-368.
30. Di Pietro R, Mariggio MA, Guarnieri S, Sancilio S, Giardinelli A, et al. (2006) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture. J Cell Biochem 97: 782-794.
31. Al-Aly, Z, (2009) The new role of calcimimetics as vasculotropic agents. Kidney Int 75: 9-12.
32. Wonneberger K, Scofield MA, Wangemann P, (2000) Evidence for a calcium-sensing receptor in the vascular smooth muscle cells of the spiral modiolar artery. J Membr Biol 175: 203-212.
33. Carrasco FR, Perez-Flores I, Calvo N, Ridao N, Sanchez A, et al. (2009) Treatment of persistent hyperparathyroidism in renal transplant patients with cinacalcet improves control of blood pressure. Transplant Proc 41: 2385-2387.
34. Baylis C, (2008) Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol 294: F1-9.
35. Kone BC, Kuncewicz T, Zhang W, Yu ZY, (2003) Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide. Am J Physiol Renal Physiol 285: F178-190.
36. Shaul PW, (2002) Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 64: 749-774.
37. Gorfien S, Spector A, DeLuca D, Weiss S, (1993) Growth and physiological functions of vascular endothelial cells in a new serum-free medium (SFM). Exp Cell Res 206: 291-301.
38. Wang H, Joseph JA, (1999) Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 27: 612-616.
39. Pandolfi A, Grilli A, Cilli C, Patruno A, Giaccari A, et al. (2003) Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation. J Cell Physiol 196: 378-385.